St. Jude Medical (STJ +3.2%) trades up after its Q4 beat expectations across the board. Despite...

|About: St. Jude Medical, Inc. (STJ)|By:, SA News Editor

St. Jude Medical (STJ +3.2%) trades up after its Q4 beat expectations across the board. Despite the earnings beat and today's price action, profit dipped 21% Y/Y as cardiac rhythm management sales declined due to concerns of overuse and a DOJ investigation. Like most of the industry, STJ continues to be challenged by pricing pressures from hospitals and more potential cuts in government health-care spending.